Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome

Pilar Nozal, Maria E. Bernabéu-Herrero, Barbara Uzonyi, Ágnes Szilágyi, Satu Hyvärinen, Zoltán Prohászka, T. Sakari Jokiranta, Pilar Sánchez-Corral, Margarita López-Trascasa, Mihály Józsi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Factor H (FH) autoantibodies are present in 6-10% of atypical hemolytic uremic syndrome (aHUS) patients, most of whom have homozygous deficiency of the FH-related protein FHR-1. Although the pathogenic role of the autoantibodies is established, little is known about their molecular characteristics and changes over time. Here, we describe the specificity and other immunological features of anti-FH autoantibodies in the Spanish and Hungarian aHUS cohorts. A total of 19 patients were included and serial samples of 14 of them were available. FH autoantibodies from FHR-1 deficient patients ( n= 13) mainly recognized FH, its SCR19-20 fragment and FHR-1, but autoantibody specificity in patients who are homo- or heterozygous for the CFHR1 gene ( n= 6) was heterogeneous. No significant changes apart from total antibody titer were observed during follow-up in each patient. Fine epitope mapping with recombinant FH SCR19-20 containing single amino acid mutations showed significantly reduced binding in 6 out of 14 patients. In most cases, autoantibody binding to residues 1183-1189 and 1210-1215 was impaired, revealing a major common autoantibody epitope. Avidities showed variations between patients, but in most cases the avidity index did not change upon time. Most autoantibodies were IgG3, and all but three presented only with kappa or with lambda light chains. Although the pathogenic role of anti-FH autoantibodies in aHUS is well established, this study shows autoantibody heterogeneity among patients, but no significant variation in their characteristics over time in each patient. The presence of a single light chain in 16 out of 19 patients and the limited number of recognized epitopes suggest a restricted autoantibody response in most patients.

Original languageEnglish
Pages (from-to)47-55
Number of pages9
JournalMolecular Immunology
Volume70
DOIs
Publication statusPublished - Feb 1 2016

Keywords

  • Atypical hemolytic uremic syndrome
  • Autoantibody
  • Autoimmunity
  • Avidity
  • Epitope mapping
  • Factor H

ASJC Scopus subject areas

  • Immunology
  • Molecular Biology

Fingerprint Dive into the research topics of 'Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome'. Together they form a unique fingerprint.

  • Cite this

    Nozal, P., Bernabéu-Herrero, M. E., Uzonyi, B., Szilágyi, Á., Hyvärinen, S., Prohászka, Z., Jokiranta, T. S., Sánchez-Corral, P., López-Trascasa, M., & Józsi, M. (2016). Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome. Molecular Immunology, 70, 47-55. https://doi.org/10.1016/j.molimm.2015.12.005